- Home
- ELAN vs LNTH Comparison
ELAN vs LNTH Comparison
Compare ELAN & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELAN
- LNTH
- Stock Information
- Founded
- ELAN 1954
- LNTH 1956
- Country
- ELAN United States
- LNTH United States
- Employees
- ELAN N/A
- LNTH N/A
- Industry
- ELAN Biotechnology: Pharmaceutical Preparations
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ELAN Health Care
- LNTH Health Care
- Exchange
- ELAN Nasdaq
- LNTH Nasdaq
- Market Cap
- ELAN 6.3B
- LNTH 7.2B
- IPO Year
- ELAN 2018
- LNTH 2015
- Fundamental
- Price
- ELAN $13.81
- LNTH $77.42
- Analyst Decision
- ELAN Buy
- LNTH Strong Buy
- Analyst Count
- ELAN 6
- LNTH 7
- Target Price
- ELAN $17.00
- LNTH $121.86
- AVG Volume (30 Days)
- ELAN 4.7M
- LNTH 1.3M
- Earning Date
- ELAN 11-07-2024
- LNTH 11-06-2024
- Dividend Yield
- ELAN N/A
- LNTH N/A
- EPS Growth
- ELAN N/A
- LNTH 304.57
- EPS
- ELAN 0.41
- LNTH 6.02
- Revenue
- ELAN $4,454,000,000.00
- LNTH $1,496,799,000.00
- Revenue This Year
- ELAN $2.22
- LNTH $19.56
- Revenue Next Year
- ELAN $2.77
- LNTH $6.32
- P/E Ratio
- ELAN $34.22
- LNTH $13.43
- Revenue Growth
- ELAN 1.99
- LNTH 24.15
- 52 Week Low
- ELAN $11.20
- LNTH $50.20
- 52 Week High
- ELAN $18.80
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- ELAN 53.55
- LNTH 25.24
- Support Level
- ELAN $12.35
- LNTH $79.58
- Resistance Level
- ELAN $14.71
- LNTH $118.21
- Average True Range (ATR)
- ELAN 0.47
- LNTH 5.40
- MACD
- ELAN 0.18
- LNTH -2.95
- Stochastic Oscillator
- ELAN 60.21
- LNTH 1.99
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.